Ontrak (OTRK) 10-Q 15 May 18 2018 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2018	May 14, 2018
Document Information [Line Items]
Entity Registrant Name	CATASYS, INC.
Entity Central Index Key	1,136,174
Trading Symbol	cats
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		15,913,171
Document Type	10-Q
Document Period End Date	Mar. 31, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current assets
Cash and cash equivalents	$ 1,354	$ 4,779
Receivables, net of allowance for doubtful accounts of $0 and $476, respectively	1,211	511
Prepaids and other current assets	354	366
Total current assets	2,919	5,656
Long-term assets
Property and equipment, net of accumulated depreciation of $1,627 and $1,542, respectively	527	612
Deposits and other assets	336	336
Total Assets	3,782	6,604
Current liabilities
Accounts payable	734	980
Accrued compensation and benefits	1,036	1,177
Deferred revenue	1,689	2,914
Other accrued liabilities	1,200	578
Total current liabilities	4,659	5,649
Long-term liabilities
Deferred rent and other long-term liabilities		25
Capital leases		2
Warrant liabilities	40	30
Total Liabilities	4,699	5,706
Stockholders' equity/(deficit)
Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value; 500,000,000 shares authorized; 15,913,171 and 15,889,171 shares issued and outstanding at March 31, 2018 and December 31, 2017, respectively	2	2
Additional paid-in-capital	294,746	294,220
Retained earnings	(295,665)	(293,324)
Total Stockholders' Equity/(Deficit)	(917)	898
Total Liabilities and Stockholders' Equity/(Deficit)	$ 3,782	$ 6,604

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Receivables, allowance for doubtful accounts	$ 0	$ 476
Property and equipment, accumulated dereciation	$ 1,627	$ 1,542
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	15,913,171	15,889,171
Common stock, shares outstanding (in shares)	15,913,171	15,889,171

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
Revenues:
Healthcare services revenues		$ 1,911,000	$ 1,822,000
Operating expenses
Cost of healthcare services		2,287,000	1,365,000
General and administrative		3,786,000	2,629,000
Depreciation and amortization		85,000	39,000
Total operating expenses		6,158,000	4,033,000
Loss from operations		(4,247,000)	(2,211,000)
Other income		40,000	14,000
Interest expense		(1,000)	(2,867,000)
Loss on conversion of note			(926,000)
Change in fair value of warrant liability		(10,000)	(5,181,000)
Change in fair value of derivative liability			(10,596,000)
Loss from operations before provision for income taxes		(4,218,000)	(21,767,000)
Provision for income taxes		0	1,000
Net Loss		$ (4,218,000)	$ (21,768,000)
Basic and diluted net loss from operations per share: (in dollars per share)		$ (0.27)	$ (2.35)
Basic and diluted weighted number of shares outstanding (in shares)	[1]	15,898	9,246
[1]	The condensed consolidated financial statements have been retroactively restated to reflect the 1-for-6 reverse-stock split that occurred on April 25, 2017.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals)	Apr. 25, 2017	Mar. 31, 2017
Reverse Stock Split [Member]
Reverse stock split	6	6

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating activities:
Net loss	$ (4,218,000)	$ (21,768,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	85,000	39,000
Issuance costs included in interest expense		2,622,000
Issuance of stock and warrants	112,000	117,000
Provision for doubtful accounts		149,000
Deferred rent	(22,000)	(20,000)
Share-based compensation expense	328,000	127,000
Fair value adjustment on derivative liability		10,596,000
Fair value adjustment on warrant liability	10,000	5,181,000
Loss on conversion of note		926,000
Changes in current assets and liabilities:
Receivables	(700,000)	(360,000)
Prepaids and other current assets	12,000	(176,000)
Deferred revenue	652,000	418,000
Accounts payable and other accrued liabilities	239,000	534,000
Net cash used in operating activities	(3,416,000)	(1,615,000)
Investing activities:
Purchases of property and equipment		(49,000)
Net cash used in investing activities		(49,000)
Financing activities:
Proceeds from bridge loan		1,115,000
Capital lease obligations	(9,000)	(11,000)
Net cash (used in)/provided by financing activities	(9,000)	1,104,000
Net decrease in cash and cash equivalents	(3,425,000)	(560,000)
Cash and cash equivalents at beginning of period	4,779,000	851,000
Cash and cash equivalents at end of period	1,354,000	291,000
Supplemental disclosure of cash paid
Income taxes		39,000
Supplemental disclosure of non-cash activity
Common stock issued for investor relations services	112,000	117,000
Warrants issued for investor relations services	85,000
Warrants Issued for Services [Member]
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of stock and warrants	$ 86,000

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - 3 months ended Mar. 31, 2018 - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2017	15,889,171			15,889,171
Balance at Dec. 31, 2017	$ 2	$ 294,220	$ (293,324)	$ 898
Adoption of accounting standard at Dec. 31, 2017			1,877	1,877
Balance at Dec. 31, 2017	$ 2	294,220	(291,447)	$ 2,775
Common stock issued for outside services (in shares)	24,000			24,000
Common stock issued for outside services		112		$ 112
Warrants issued for services		86		86
Share-based Compensation Expense		328		328
Net loss			(4,218)	$ (4,218)
Balance (in shares) at Mar. 31, 2018	15,913,171			15,913,171
Balance at Mar. 31, 2018	$ 2	$ 294,746	$ (295,665)	$ (917)

Note 1 - Basis of Consolidation

Note 1 - Basis of Consolidation, Presentation and Liquidity	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Note 1. Liquidity We harness proprietary big data predictive analytics, artificial intelligence and telehealth, combined with human intervention, to deliver improved member health and cost savings to health plans through integrated technology enabled treatment solutions. It is our mission to provide access to affordable and effective care, thereby improving health and reducing cost of care for people who suffer from the medical consequences of behavioral health conditions; helping these people and their families achieve and maintain better lives. The accompanying unaudited condensed consolidated financial statements for Catasys, Inc. and its subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and instructions to Form 10 not not may 10 December 31, 2017, December 31, 2017, Our ability to fund our ongoing operations is dependent on increasing the number of members that are eligible for our solutions by signing new contracts, identifying more eligible members in existing contracts, and generating fees from existing and new contracts and the success of management’s plan to increase revenue and continue to control expenses. We currently operate our On Trak nineteen 2018. Management’s Plans Historically we have seen and continue to see net losses, net loss from operations, negative cash flow from operating activities, and historical working capital deficits as we continue through a period of rapid growth. These conditions raise substantial doubt about our ability to continue as a going concern. The accompanying financial statements do not Trak first 2018. 2018. twelve not All inter-company transactions have been eliminated in consolidation.

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 2. Revenue Recognition Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation may i.e. not third The following table disaggregates our revenue by contract (in thousands): For the period ended Revenue Percentage Commercial $ 1,100 58 % Government 811 42 % $ 1,911 100 % Because the Company’s contracts have an expected duration of one 606 10 50 14 not Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the On Trak March 31, 2018. Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM Cash Equivalents and Concentration of Credit Risk We consider all highly liquid investments with an original maturity of three may March 31, 2018, $1.2 For the three March 31, 2018, five 89% 22%, 20%, 18%, 15%, 14% four 83% 37%, 18%, 15%, 13% Basic and Diluted Loss per Share Basic loss per share is computed by dividing the net loss to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of 3,920,531 1,928,431 three March 31, 2018 2017, Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five March 31, 2018, 1,885,003 338,178 692,184 2017 Share-based compensation expense attributable to operations were $328,000 $127,000 three March 31, 2018 2017, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the three March 31, 2018 2017, There were no three March 31, 2018 2017, 2017 three March 31, 2018 Weighted Avg. Shares Exercise Price Balance December 31, 2017 1,885,383 $ 11.46 Granted - - Cancelled (380 ) 683.91 Balance March 31, 2018 1,885,003 $ 11.32 The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three March 31, 2018 2017, No. 107 110 As of March 31, 2018, $4.4 2017 3.26 Stock Options and Warrants – Non-employees We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no three March 31, 2018 2017, no three March 31, 2018 2017, There were 24,000 0 three March 31, 2018 2017, There were 2,035,528 1,684,578 March 31, 2018 2017, Common Stock There were 24,000 14,492 three March 31, 2018 2017, Income Taxes We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of March 31, 2018. not March 31, 2018. 740, not not We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% may 50% no March 31, 2018 Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table summarizes fair value measurements by level at March 31, 2018 Balance at March 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 40 40 Total liabilities - - 40 40 Carrying amounts reported in the condensed consolidated balance sheet of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their relatively short maturity. The fair value of borrowings is not Financial instruments classified as Level III in the fair value hierarchy as of March 31, 2018, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three March 31, 2018: Level III Warrant (Dollars in thousands) Liabilities Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 10 Balance as of March 31, 2018 $ 40 Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven Warrant Liabilities The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions: March 31, 201 8 Expected volatility 102.90% Risk-free interest rate 2.27% Weighted average expected lives in years 2.04 Expected dividend 0% We have issued warrants to purchase common stock in February 2012, April 2015, July 2015, August 2016, December 2016, January 2017, February 2017, March 2017, June 2017, February 2018. 11,049 For the three March 31, 2018 2017, $10,000 $5.2 Recently Issued or Newly Adopted Accounting Standards In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2014 09, 2014 09, December 15, 2017. 2016 10 $1.9 January 1, 2018 ( 3 In February 2016, No. 2016 02, Leases (Topic 842 2016 02” . 606, Revenue from Contracts with Customers no 2016 02 December 15, 2018, January 1, 2019, not may not In June 2016, 2016 13, Financial Instruments - Credit Losses not first 2021. In July 2017, 2017 11, Earnings Per Share (Topic 260 480 815 no no December 15, 2018, not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not

Note 3 - ASC 606

Note 3 - ASC 606	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 3. ASC 606 In May 2014, No. 2014 09, 606 2014 09” 2014 09 605 605” 605. 606 We adopted ASC 606 January 1, 2018 not January 1, 2018 ASU 2014 09, Balance at December 31, 2017 Adjustments Due to Adoption of ASC606 Balance at January 1, 2018 Balance Sheet Liabilities Deferred revenue (2,914 ) 1,877 (1,037 ) Equity Retained earnings (293,324 ) 1,877 (291,447 ) In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our consolidated income statement and balance sheet was as follows (in thousands): For the period ended March 31, 2018 As Balances Without Adoption of Effect of Change Income Statement Revenues Healthcare services revenues $ 1,911 $ 1,152 $ 759 Net loss (4,218 ) (4,977 ) 759

Note 4 - Restatement of Financi

Note 4 - Restatement of Financial Statements	3 Months Ended
	Mar. 31, 2018
Notes to Financial Statements
Accounting Changes and Error Corrections [Text Block]	Note 4 . Restatement of Financial Statements The financial statements have been retroactively restated to reflect the 1 6 April 25, 2017.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2018
Accounting Policies [Abstract]
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition Revenue from contracts with customers is recognized when, or as, we satisfy our performance obligations by transferring the promised goods or services to the customers. A good or service is transferred to a customer when, or as, the customer obtains control of that good or service. A performance obligation may i.e. not third The following table disaggregates our revenue by contract (in thousands): For the period ended Revenue Percentage Commercial $ 1,100 58 % Government 811 42 % $ 1,911 100 % Because the Company’s contracts have an expected duration of one 606 10 50 14 not Our Catasys contracts are generally designed to provide cash fees to us on a monthly basis, an upfront case rate, or fee for service based on enrolled members. The Company’s performance obligation is satisfied over time as the On Trak March 31, 2018.
Cost of Sales, Policy [Policy Text Block]	Cost of Services Cost of healthcare services consists primarily of salaries related to our care coaches, outreach specialists and other staff directly involved in member care, healthcare provider claims payments, and fees charged by our third third Trak TM
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Equivalents and Concentration of Credit Risk We consider all highly liquid investments with an original maturity of three may March 31, 2018, $1.2 For the three March 31, 2018, five 89% 22%, 20%, 18%, 15%, 14% four 83% 37%, 18%, 15%, 13%
Earnings Per Share, Policy [Policy Text Block]	Basic and Diluted Loss per Share Basic loss per share is computed by dividing the net loss to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common stock and dilutive common equivalent shares outstanding during the period. Common equivalent shares, consisting of 3,920,531 1,928,431 three March 31, 2018 2017,
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Share-Based Compensation Our 2017 “2017 2,333,334 243,853 2010 “2010 422A 2017 no ten three five March 31, 2018, 1,885,003 338,178 692,184 2017 Share-based compensation expense attributable to operations were $328,000 $127,000 three March 31, 2018 2017, Stock Options – Employees and Directors We measure and recognize compensation expense for all share-based payment awards made to employees and directors based on estimated fair values on the date of grant. We estimate the fair value of share-based payment awards using the Black-Scholes option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in the consolidated statements of operations. For share-based awards issued to employees and directors, share-based compensation is attributed to expense using the straight-line single option method. Share-based compensation expense recognized in our consolidated statements of operations for the three March 31, 2018 2017, There were no three March 31, 2018 2017, 2017 three March 31, 2018 Weighted Avg. Shares Exercise Price Balance December 31, 2017 1,885,383 $ 11.46 Granted - - Cancelled (380 ) 683.91 Balance March 31, 2018 1,885,003 $ 11.32 The expected volatility assumptions have been based on the historical and expected volatility of our stock, measured over a period generally commensurate with the expected term. The weighted average expected option term for the three March 31, 2018 2017, No. 107 110 As of March 31, 2018, $4.4 2017 3.26 Stock Options and Warrants – Non-employees We account for the issuance of options and warrants for services from non-employees by estimating the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the option or warrant exercise price, the market price of shares on grant date, the weighted average risk-free interest rate, the expected life of the option or warrant, and the expected volatility of our stock and the expected dividends. For options and warrants issued as compensation to non-employees for services that are fully vested and non-forfeitable at the time of issuance, the estimated value is recorded in equity and expensed when the services are performed and benefit is received. For unvested shares, the change in fair value during the period is recognized in expense using the graded vesting method. There were no three March 31, 2018 2017, no three March 31, 2018 2017, There were 24,000 0 three March 31, 2018 2017, There were 2,035,528 1,684,578 March 31, 2018 2017,
Stockholders' Equity, Policy [Policy Text Block]	Common Stock There were 24,000 14,492 three March 31, 2018 2017,
Income Tax, Policy [Policy Text Block]	Income Taxes We have recorded a full valuation allowance against our otherwise recognizable deferred tax assets as of March 31, 2018. not March 31, 2018. 740, not not We assess our income tax positions and record tax benefits for all years subject to examination based upon our evaluation of the facts, circumstances and information available at the reporting date. For those tax positions where there is greater than 50% may 50% no March 31, 2018
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure fair value. The fair value hierarchy distinguishes between ( 1 2 three three Level Input: Input Definition: Level I Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. Level II Inputs, other than quoted prices included in Level I, that are observable for the asset or liability through corroboration with market data at the measurement date. Level III Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The following table summarizes fair value measurements by level at March 31, 2018 Balance at March 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 40 40 Total liabilities - - 40 40 Carrying amounts reported in the condensed consolidated balance sheet of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximate fair value due to their relatively short maturity. The fair value of borrowings is not Financial instruments classified as Level III in the fair value hierarchy as of March 31, 2018, Warrant Liabilities The following table summarizes our fair value measurements using significant Level III inputs, and changes therein, for the three March 31, 2018: Level III Warrant (Dollars in thousands) Liabilities Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 10 Balance as of March 31, 2018 $ 40
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost, less accumulated depreciation. Additions and improvements to property and equipment are capitalized at cost. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from two seven five seven
Derivatives, Policy [Policy Text Block]	Warrant Liabilities The warrant liabilities were calculated using the Black-Scholes model based upon the following assumptions: March 31, 201 8 Expected volatility 102.90% Risk-free interest rate 2.27% Weighted average expected lives in years 2.04 Expected dividend 0% We have issued warrants to purchase common stock in February 2012, April 2015, July 2015, August 2016, December 2016, January 2017, February 2017, March 2017, June 2017, February 2018. 11,049 For the three March 31, 2018 2017, $10,000 $5.2
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued or Newly Adopted Accounting Standards In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606 2014 09, 2014 09, December 15, 2017. 2016 10 $1.9 January 1, 2018 ( 3 In February 2016, No. 2016 02, Leases (Topic 842 2016 02” . 606, Revenue from Contracts with Customers no 2016 02 December 15, 2018, January 1, 2019, not may not In June 2016, 2016 13, Financial Instruments - Credit Losses not first 2021. In July 2017, 2017 11, Earnings Per Share (Topic 260 480 815 no no December 15, 2018, not In August 2014, 2014 15, Presentation of Financial Statements—Going Concern (Subtopic 205 40 2014 15” . 2014 15 not may no one one not 2014 15 December 15, 2016. 2014 15 not

Note 2 - Summary of Significa13

Note 2 - Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Disaggregation of Revenue [Table Text Block]	For the period ended Revenue Percentage Commercial $ 1,100 58 % Government 811 42 % $ 1,911 100 %
Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Avg. Shares Exercise Price Balance December 31, 2017 1,885,383 $ 11.46 Granted - - Cancelled (380 ) 683.91 Balance March 31, 2018 1,885,003 $ 11.32
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Balance at March 31, 2018 (Amounts in thousands) Level I Level II Level III Total Certificates of deposit 71 - - 71 Total assets 71 - - 71 Warrant liabilities - - 40 40 Total liabilities - - 40 40
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Level III Warrant (Dollars in thousands) Liabilities Balance as of December 31, 2017 $ 30 Issuance of warrants - Change in fair value 10 Balance as of March 31, 2018 $ 40
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]	March 31, 201 8 Expected volatility 102.90% Risk-free interest rate 2.27% Weighted average expected lives in years 2.04 Expected dividend 0%

Note 3 - ASC 606 (Tables)

Note 3 - ASC 606 (Tables)	3 Months Ended
	Mar. 31, 2018
Notes Tables
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	Balance at December 31, 2017 Adjustments Due to Adoption of ASC606 Balance at January 1, 2018 Balance Sheet Liabilities Deferred revenue (2,914 ) 1,877 (1,037 ) Equity Retained earnings (293,324 ) 1,877 (291,447 ) For the period ended March 31, 2018 As Balances Without Adoption of Effect of Change Income Statement Revenues Healthcare services revenues $ 1,911 $ 1,152 $ 759 Net loss (4,218 ) (4,977 ) 759

Note 2 - Summary of Significa15

Note 2 - Summary of Significant Accounting Policies (Details Textual)	3 Months Ended
	Mar. 31, 2018USD ($)shares	Mar. 31, 2017USD ($)shares	Jan. 01, 2018USD ($)	Dec. 31, 2017USD ($)
Cash, Uninsured Amount | $	$ 1,200,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,920,531	1,928,431
Share-based Compensation, Total | $	$ 328,000	$ 127,000
Class of Warrant or Right, Outstanding	2,035,528	1,684,578
Stock Issued During Period, Shares, Issued for Services	24,000	14,492
Income Tax Expense (Benefit), Total | $	$ 0	$ 1,000
Fair Value Adjustment of Warrants | $	10,000	$ 5,181,000
Retained Earnings (Accumulated Deficit), Ending Balance | $	(295,665,000)		$ (291,447,000)	$ (293,324,000)
Contract with Customer, Liability, Current | $	$ 1,689,000		1,037,000	$ 2,914,000
Accounting Standards Update 2014-09 [Member]
Retained Earnings (Accumulated Deficit), Ending Balance | $			1,877,000
Contract with Customer, Liability, Current | $			$ (1,877,000)
Warrants Related to Investor Relations Services [Member]
Class of Warrant or Right, Issued During Period	24,000	0
Warrants Not Subject to Amendment [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	11,049
Minimum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life	2 years
Minimum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life	5 years
Maximum [Member] | Furniture and Equipment [Member]
Property, Plant and Equipment, Useful Life	7 years
Maximum [Member] | Leasehold Improvements [Member]
Property, Plant and Equipment, Useful Life	7 years
The 2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	2,333,334
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	1,885,003
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares	338,178
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	692,184
Share-based Compensation, Total | $	$ 328,000	$ 127,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total | $	$ 4,400,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	3 years 94 days
The 2017 Stock Incentive Plan [Member] | Nonemployees [Member]
Share-based Compensation, Total | $	$ 0	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0	0
The 2017 Stock Incentive Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
The 2017 Stock Incentive Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	5 years
The 2010 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	243,853
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Number of Major Customers	5
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Five Customers [Member]
Concentration Risk, Percentage	89.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage	22.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Concentration Risk, Percentage	20.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Three [Member]
Concentration Risk, Percentage	18.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Four [Member]
Concentration Risk, Percentage	15.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Customer Five [Member]
Concentration Risk, Percentage	14.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Number of Major Customers	4
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Concentration Risk, Percentage	37.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Concentration Risk, Percentage	18.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Three [Member]
Concentration Risk, Percentage	15.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Customer Four [Member]
Concentration Risk, Percentage	13.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Four Customers [Member]
Concentration Risk, Percentage	83.00%

Note 2 - Summary of Significa16

Note 2 - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenues	$ 1,911	$ 1,822
Revenues, percentage	100.00%
Commercial [Member]
Revenues	$ 1,100
Revenues, percentage	58.00%
Government Contract [Member]
Revenues	$ 811
Revenues, percentage	42.00%

Note 2 - Summary of Significa17

Note 2 - Summary of Significant Accounting Policies - Employee and Director Stock Option Activity (Details) - Employees and Directors [Member]	3 Months Ended
	Mar. 31, 2018$ / sharesshares
Balance, shares (in shares) | shares	1,885,383
Balance, weighted average exercise price (in dollars per share) | $ / shares	$ 11.46
Granted, shares (in shares) | shares
Granted, weighted average exercise price (in dollars per share) | $ / shares
Cancelled, shares (in shares) | shares	(380)
Cancelled, weighted average exercise price (i (in dollars per share) | $ / shares	$ 683.91
Balance, shares (in shares) | shares	1,885,003
Balance, weighted average exercise price (in dollars per share) | $ / shares	$ 11.32

Note 2 - Summary of Significa18

Note 2 - Summary of Significant Accounting Policies - Fair Value, Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Total assets	$ 71
Warrant liabilities	40	$ 30
Total liabilities	40
Certificates of Deposit [Member]
Certificates of deposit	71
Fair Value, Inputs, Level 1 [Member]
Total assets	71
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 1 [Member] | Certificates of Deposit [Member]
Certificates of deposit	71
Fair Value, Inputs, Level 2 [Member]
Total assets
Warrant liabilities
Total liabilities
Fair Value, Inputs, Level 2 [Member] | Certificates of Deposit [Member]
Certificates of deposit
Fair Value, Inputs, Level 3 [Member]
Total assets
Warrant liabilities	40
Total liabilities	40
Fair Value, Inputs, Level 3 [Member] | Certificates of Deposit [Member]
Certificates of deposit

Note 2 - Summary of Significa19

Note 2 - Summary of Significant Accounting Policies - Fair Value Measurements Using Significant Level III Inputs (Details) - Warrants [Member] - Fair Value, Inputs, Level 3 [Member] $ in Thousands	3 Months Ended
	Mar. 31, 2018USD ($)
Balance	$ 30
Issuance (exercise) of warrants, net
Change in fair value	10
Balance	$ 40

Note 2 - Summary of Significa20

Note 2 - Summary of Significant Accounting Policies - Fair Value Assumptions, Warrant Liabilities (Details)	Mar. 31, 2018
Measurement Input, Price Volatility [Member]
Warrant liability assumptions	102.9
Measurement Input, Risk Free Interest Rate [Member]
Warrant liability assumptions	2.27
Measurement Input, Expected Term [Member]
Warrant liability assumptions	2.04
Measurement Input, Expected Dividend Rate [Member]
Warrant liability assumptions	0

Note 3 - ASC 606 - Adoption of

Note 3 - ASC 606 - Adoption of ASC 606 (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Jan. 01, 2018	Dec. 31, 2017
Deferred revenue	$ (1,689)		$ (1,037)	$ (2,914)
Retained earnings	(295,665)		(291,447)	$ (293,324)
Healthcare services revenues	1,911	$ 1,822
Net loss	(4,218)	$ (21,768)
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Healthcare services revenues	1,152
Net loss	(4,977)
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Healthcare services revenues	759
Net loss	$ 759
Accounting Standards Update 2014-09 [Member]
Deferred revenue			1,877
Retained earnings			$ 1,877

Note 4 - Restatement of Finan22

Note 4 - Restatement of Financial Statements (Details Textual)	Apr. 25, 2017	Mar. 31, 2017
Reverse Stock Split [Member]
Stockholders' Equity Note, Stock Split, Conversion Ratio	6	6